In Brief: FDA Division of OTC Drug Evaluation
This article was originally published in The Rose Sheet
FDA Division of OTC Drug Evaluation: Debra Bowen, MD, has been officially named director of FDA's Division of OTC Drug Evaluation, Office of Drug Evaluation V Director Michael Weintraub, MD, announced at CTFA's "Meet the Regulators" conference Jan. 24 in Washington, DC. Bowen was appointed acting director of the division in September following the reorganization of FDA's Center for Drug Evaluation and Research ("The Rose Sheet" Sept. 25, p. 9)...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review